ACRS

Aclaris Therapeutics develops and researches treatments for immune-inflammatory skin conditions like alopecia areata and vitiligo. Doctors and patients use these potential treatments to address hair loss and skin discoloration caused by autoimmune responses. The company makes money through partnerships with larger pharmaceutical companies for drug development and could generate revenue from future drug sales if treatments receive regulatory approval.